← Back to Blog

Is Quercetin Anti-Inflammatory? What the Evidence Shows

Quercetin is one of the most abundant flavonoids in the human diet, found in everyday foods from onions to apples to berries. Its reputation as a natural anti-inflammatory is well established in the laboratory, but what do the actual human trials and meta-analyses show, and who is most likely to see a meaningful effect?

Written by Sydney Murphy, CMO & Digital Products Officer. Reviewed by the Sensa Wellness editorial team. Written to reflect current, publicly available inflammation research.

The short answer

Yes, quercetin has genuine anti-inflammatory effects that are supported by human trial data. Multiple meta-analyses of randomized controlled trials show that quercetin supplementation produces a statistically significant reduction in C-reactive protein (CRP), the standard blood marker of systemic inflammation. The effect is real but modest in the general population, and it appears most pronounced in people with existing health conditions or those who take doses at or above 500 mg per day. For most healthy adults, getting quercetin through a varied diet of fruits and vegetables is a sensible baseline, while supplementation is a decision best made with a healthcare provider.

Quercetin sits in an interesting category: a compound that scientists have studied intensively at the cellular level for decades, whose anti-inflammatory actions look compelling in cell cultures and animal models, but whose effects in real humans require a more careful reading of the evidence. It is easy to find breathless claims online about quercetin being a miracle anti-inflammatory. It is equally easy to find dismissive commentary suggesting that food-derived polyphenols do nothing once they reach the bloodstream. The honest picture, as with most nutrition science, lies somewhere in between.

Quercetin is a polyphenolic flavonoid naturally present in many plant foods. Chemically, it belongs to the flavonol subclass and acts as both an antioxidant and a modulator of several inflammatory signaling pathways in human cells.

What Quercetin Is and Where It Comes From

Quercetin is not a vitamin or mineral but a phytochemical, a biologically active compound that plants produce primarily for their own defense. It accumulates in the skins and outer layers of fruits and vegetables, which is why red onions contain more of it than white onions, and why unpeeled apples deliver more than peeled ones. The list of quercetin-rich foods is long and includes red and yellow onions, apples, capers, kale, broccoli, berries (particularly blueberries and cranberries), grapes, citrus fruits, and green tea. Black tea and red wine also contribute meaningfully to quercetin intake in populations that consume them regularly.

Estimates of average dietary quercetin intake in Western populations typically range from about 10 to 100 milligrams per day, depending heavily on how many plant foods are consumed. This range matters because the doses used in clinical trials are often considerably higher, frequently 500 mg per day or more in supplement form, sometimes combined with bromelain or vitamin C to improve absorption. When you read that quercetin "reduced CRP in a clinical trial," it is worth checking the dose, because food-derived intake and supplement doses occupy very different territory.

Bioavailability is a genuine limitation with quercetin. Like many polyphenols, it is not particularly well absorbed in its free form. In foods, quercetin is mostly bound to sugar molecules as glycosides, and the type of sugar attached strongly influences how much gets absorbed in the small intestine versus broken down by gut bacteria in the colon. Processing quercetin glycosides through the gut microbiome produces metabolites that may have their own biological activity, but the picture is complex. Supplement forms vary in their absorption characteristics, and some formulations pair quercetin with phospholipids or other compounds specifically to improve bioavailability.

How Quercetin Suppresses Inflammatory Signaling

At the cellular level, quercetin targets several key nodes in the inflammatory cascade, with NF-kappa-B (NF-kB) as perhaps the most important. NF-kB is a master transcription factor that, when activated, switches on dozens of pro-inflammatory genes and drives the production of cytokines including interleukin-6 (IL-6), interleukin-1 beta (IL-1B), and tumor necrosis factor alpha (TNF-alpha). These cytokines in turn stimulate the liver to produce CRP, which is why CRP serves as a downstream readout of this entire signaling network. Quercetin inhibits the upstream activation of NF-kB, partly by blocking the kinase (IKK) that is required to set the cascade in motion.

A 2017 review in the European Journal of Medicinal Chemistry, covering flavonoids' anti-inflammatory mechanisms, confirmed that quercetin and related compounds reduce the expression of pro-inflammatory cytokines including IL-6, TNF-alpha, IL-1 beta, and COX-2, with the effects operating through modulation of NF-kB and MAPK signaling pathways, as demonstrated across in vivo and in vitro data (Spagnuolo et al., 2017). COX-2 is the enzyme that also happens to be the target of nonsteroidal anti-inflammatory drugs such as ibuprofen, which gives some context for the kind of cellular machinery quercetin is working with, albeit through a different and more indirect mechanism.

Quercetin also acts as a direct antioxidant, scavenging free radicals that would otherwise activate inflammatory signaling. Oxidative stress, the accumulation of reactive oxygen species inside cells, is one of the most direct triggers of NF-kB activation and downstream inflammation. By neutralizing these reactive molecules, quercetin reduces the upstream pressure on inflammatory pathways. This antioxidant action partly explains why quercetin's effects in humans look somewhat different from those of pure anti-inflammatory drugs: its influence is diffuse and systemic rather than targeted at a single enzyme.

A third mechanism involves mast cells and histamine. Quercetin inhibits the degranulation of mast cells, the immune cells that release histamine and other pro-inflammatory compounds during allergic and hypersensitivity responses. This property has led to interest in quercetin for allergy and airway inflammation, though that is a somewhat separate line of research from the CRP-focused data discussed in the following section.

What the Human Trials and Meta-Analyses Show

The clearest evidence from human trials comes from meta-analyses that pool multiple randomized controlled trials measuring CRP. A 2017 systematic review and meta-analysis published in the European Journal of Clinical Nutrition pooled seven randomized controlled trials (10 treatment arms) and found a significant reduction in circulating CRP following quercetin supplementation, with a weighted mean difference of -0.33 mg/L (95% confidence interval: -0.50 to -0.15; P less than 0.001) compared with placebo groups (Mohammadi-Sartang et al., 2017). The subgroup analysis showed the effect was particularly strong at doses of 500 mg per day or higher, and in participants whose baseline CRP was below 3 mg/L, the range often described as low-grade or subclinical inflammation.

A larger meta-analysis focused on people with metabolic syndrome and related conditions found an even more pronounced CRP-lowering effect. This 2019 analysis in Critical Reviews in Food Science and Nutrition pooled 16 randomized controlled trials and found quercetin supplementation significantly decreased CRP with a standardized mean difference of -0.64 (95% CI: -1.03 to -0.25; P equal to 0.001) (Tabrizi et al., 2019). The same analysis showed quercetin also significantly reduced total cholesterol and LDL cholesterol in this population, while effects on other cytokines like IL-6 and TNF-alpha were not statistically significant in the pooled data. The larger effect size in metabolic syndrome patients compared with the general population is consistent with a pattern seen across many nutritional interventions: people with more room to improve tend to show bigger responses.

A 2019 meta-analysis in the International Journal of Food Sciences and Nutrition offered a useful nuance. When pooling all trials regardless of participant characteristics, the overall effect on CRP, IL-6, and TNF-alpha was not statistically significant. But subgroup analyses told a different story: CRP was significantly reduced in participants with diagnosed diseases (standardized mean difference: -0.24, 95% CI: -0.49 to 0.00), and IL-6 was significantly reduced in females and in participants with diagnosed diseases, particularly at higher doses (Ou et al., 2019). The authors concluded that quercetin consumption is a promising strategy for chronic disease management, while noting that the overall evidence across unselected healthy subjects was less convincing.

Reading these three meta-analyses together paints a coherent picture. Quercetin genuinely lowers CRP in controlled trials, but the effect is real and consistent primarily when doses are meaningful (at or above 500 mg per day) and when participants have underlying inflammation, a metabolic condition, or a diagnosed health issue. In healthy adults with already-low CRP, the signal is weaker and less consistent. This is not a failure of the compound so much as a reflection of how inflammatory biology works: interventions tend to show larger effects when inflammation is higher to begin with.

Dose, Bioavailability, and Practical Considerations

The 500 mg per day threshold that appears in the clinical trial literature is worth taking seriously, because it is far above what most people get from diet alone. To put this in perspective: a medium red onion, one of the richest dietary sources, might provide 20 to 50 mg of quercetin depending on variety and preparation. Reaching 500 mg through food alone would require an impractically large quantity. This is why the trial literature is essentially a supplement literature rather than a diet-change literature, even though quercetin arrives in the body through food as well.

Quercetin is generally considered safe across the doses used in clinical trials, and there is no established toxic dose in humans from oral intake at the levels typically studied. Some theoretical concern exists around very high doses based on in vitro data showing pro-oxidant effects in cells at extremely high concentrations, but these levels are not reachable through oral supplementation. The more practical considerations are interactions with certain medications: quercetin can inhibit cytochrome P450 enzymes involved in drug metabolism, potentially affecting the clearance of medications including some antibiotics, cyclosporine, and others. Anyone taking prescription medications should discuss quercetin supplementation with a healthcare provider before starting.

Not all quercetin supplements are equivalent, and the form matters. Plain quercetin aglycone (the free, unbound form) has modest bioavailability on its own. Quercetin phytosome (quercetin bound to phospholipids from sunflower lecithin) has shown substantially better absorption in pharmacokinetic studies compared with standard quercetin. Some formulations combine quercetin with bromelain, a pineapple-derived enzyme, or with vitamin C, based on evidence that these combinations may enhance uptake or extend the anti-inflammatory effect. When evaluating a supplement, the form of quercetin used and the presence of absorption enhancers is at least as important as the stated milligram dose.

Quercetin in the Context of Diet and Lifestyle

One of the strongest arguments for a quercetin-rich diet is that it is inseparable from eating a generally anti-inflammatory dietary pattern. Foods high in quercetin, including onions, leafy greens, berries, and apples, are also high in fiber, other polyphenols, and vitamins that collectively support a low-inflammation state. Isolating quercetin's contribution from the broader effect of a vegetable-rich diet in observational studies is virtually impossible. This is not a criticism of quercetin specifically but a reminder that individual compounds found in whole foods tend to perform best in the context of the dietary pattern they come from.

The Mediterranean diet, one of the best-studied dietary patterns in relation to inflammation, is naturally high in quercetin. Its heavy use of onions, tomatoes, legumes, leafy greens, apples, and herbs delivers quercetin alongside olives, fish-derived omega-3 fatty acids, and abundant fiber. The anti-inflammatory track record of the Mediterranean diet in clinical research is considerably stronger than that of quercetin supplementation in isolation, which speaks to the value of whole-diet approaches over single-compound strategies. Quercetin may be one of several active ingredients explaining part of that benefit, but it almost certainly does not explain it alone.

As a supplement, quercetin fits most naturally as one component of a broader strategy for people managing chronic low-grade inflammation, not as a first-line or standalone approach. The lifestyle drivers of CRP, including excess body fat (particularly visceral fat), poor sleep quality, physical inactivity, smoking, and ultra-processed food consumption, have larger documented effects on inflammatory markers than any single supplement. Addressing those drivers first makes the most sense, both from an evidence standpoint and because they carry benefits that extend far beyond CRP alone.

What ties all of these pieces together is measurement. CRP reflects the net result of everything influencing your inflammatory state, from your diet and sleep to your stress levels and body composition. Tracking CRP over time gives you a way to evaluate whether the changes you are making, whether adding quercetin-rich foods, reducing ultra-processed foods, improving sleep, or starting a consistent exercise habit, are actually moving the needle. Because CRP is a general wellness marker rather than a clinical diagnosis, persistent elevations are always worth discussing with a healthcare provider.

Sources

  • Mohammadi-Sartang M, Mazloom Z, Sherafatmanesh S, et al. Effects of supplementation with quercetin on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition, 2017; 71(9):1033-1039. pubmed.ncbi.nlm.nih.gov/28537580
  • Tabrizi R, Tamtaji OR, Mirhosseini N, et al. The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition, 2019; 60(11):1855-1868. pubmed.ncbi.nlm.nih.gov/31017459
  • Ou Q, Zheng Z, Zhao Y, Lin W. Impact of quercetin on systemic levels of inflammation: a meta-analysis of randomised controlled human trials. International Journal of Food Sciences and Nutrition, 2019; 71(2):152-163. pubmed.ncbi.nlm.nih.gov/31213101
  • Spagnuolo C, Moccia S, Russo GL. Anti-inflammatory effects of flavonoids in neurodegenerative disorders. European Journal of Medicinal Chemistry, 2017; 153:105-115. pubmed.ncbi.nlm.nih.gov/28923363
Share this article

Frequently Asked Questions

Is quercetin anti-inflammatory?

Yes. Quercetin inhibits the NF-kB signaling pathway that drives production of pro-inflammatory cytokines, and it acts as a direct antioxidant that reduces the oxidative stress triggering inflammatory cascades. Multiple meta-analyses of randomized controlled trials confirm quercetin supplementation significantly reduces CRP, particularly at doses of 500 mg per day or higher and in people who have underlying health conditions or elevated inflammation at baseline.

How much quercetin should I take for inflammation?

The clinical trial literature most consistently shows CRP-lowering effects at doses of 500 mg per day or above. Lower doses from diet alone (typically 10 to 100 mg per day) are beneficial as part of an overall healthy eating pattern but have not demonstrated consistent CRP effects in controlled trials. If you are considering supplementation, it is worth discussing the right dose and form with a healthcare provider, particularly if you take prescription medications, since quercetin can affect how the body processes certain drugs.

What foods are highest in quercetin?

Red and yellow onions are the richest everyday source, particularly the outer layers and skin. Capers are exceptionally concentrated but eaten in small amounts. Apples (unpeeled), blueberries, cranberries, kale, broccoli, red grapes, citrus fruits, and green and black tea are all good sources. Because quercetin concentrates in outer plant layers, minimally processed whole fruits and vegetables deliver more than peeled or heavily cooked versions.

Does quercetin lower CRP specifically?

Yes, based on the meta-analysis evidence. A 2017 meta-analysis of seven randomized controlled trials found quercetin supplementation reduced CRP by a weighted mean difference of -0.33 mg/L (P less than 0.001). A separate 2019 meta-analysis in patients with metabolic syndrome found a standardized mean difference of -0.64 in CRP. The effect is most reliably observed in populations with pre-existing conditions and at supplement doses at or above 500 mg per day.

Want to track your inflammation as part of a healthy lifestyle?

Sensa is a general wellness tool that lets you measure your CRP levels at home. No needles, no clinic visit. Track trends over time and make more informed lifestyle choices.

Buy Now

Get inflammation insights in your inbox

New articles on inflammation science, plus updates on the Sensa at-home CRP test and app.